{
    "pmcid": "10384293",
    "qa_pairs": {
        "What is a unique feature of the SARS-CoV-2 spike protein compared to the SARS-CoV-1 spike protein?": [
            "It can induce cell-cell fusion without the presence of ACE2.",
            "It requires TMPRSS2 for proteolytic cleavage.",
            "It is inhibited by antibodies targeting the receptor-binding domain.",
            "It does not require furin for cleavage."
        ],
        "Which domain of the SARS-CoV-2 spike protein is targeted by monoclonal antibodies that inhibit ACE2-independent fusion?": [
            "N-terminal domain (NTD)",
            "Receptor-binding domain (RBD)",
            "S2 subunit",
            "Transmembrane domain"
        ],
        "Which proteolytic enzyme is critical for the SARS-CoV-2 spike protein's receptor-independent fusion activity?": [
            "Furin",
            "TMPRSS2",
            "Cathepsin L",
            "Trypsin"
        ],
        "Which specific region of the SARS-CoV-2 spike protein is crucial for ACE2-independent fusion activity?": [
            "Amino acids 652-1273",
            "Amino acids 1-300",
            "Amino acids 301-651",
            "Amino acids 1274-1500"
        ],
        "Which variant of SARS-CoV-2 shows minimal fusogenic activity according to the study?": [
            "Omicron",
            "Delta",
            "Alpha",
            "Beta"
        ]
    }
}